Literature DB >> 16760678

Impact of blood pressure vs. glycemic factors on target organ damage in patients with type 2 diabetes mellitus.

Kazuo Eguchi1, Joji Ishikawa, Satoshi Hoshide, Shizukiyo Ishikawa, Kazuyuki Shimada, Kazuomi Kario.   

Abstract

The hypothesis that three measures of target organ damage in type 2 diabetics would be more closely related to blood pressure (BP) than to glycemic factors was tested by recording 24-hour ambulatory BP and glycosylated hemoglobin. The prevalence of silent cerebral infarcts with brain magnetic resonance imaging, left ventricular mass index with cardiac ultrasonography, and albuminuria in 244 asymptomatic diabetics (mean age, 65.4+/-9 years; 122 men and 122 women; hypertension, 73%) were evaluated. Multivariate analysis showed that age (standard partial regression coefficient: b=0.299; p<0.001), duration of hypertension (b=0.176; p=0.007), and 24-hour systolic BP (b=0.195; p=0.004) were significantly associated with the number of silent cerebral infarcts, but glycosylated hemoglobin (b=0.104; p=0.109) and duration of diabetes were not. Left ventricular mass index was associated with 24-hour systolic BP (b=0.377; p<0.001) and male sex (b=0.172; p=0.019). Presence of albuminuria was significantly associated with 24-hour systolic BP (b=0.209; p=0.003), duration of diabetes (b=0.154; p=0.022), cholesterol (b=0.132; p=0.042), and insulin use (b=0.150; p=0.026). In conclusion, all three measures of target organ damage were related to 24-hour BP, but only albuminuria was related to glycosylated hemoglobin in type 2 diabetics. BP may be more important than glycemic factors for predicting future cardiovascular complications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760678      PMCID: PMC8109584          DOI: 10.1111/j.1524-6175.2006.04739.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  33 in total

1.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

2.  Nephropathy in diabetes.

Authors:  Mark E Molitch; Ralph A DeFronzo; Marion J Franz; William F Keane; Carl Erik Mogensen; Hans-Henrik Parving; Michael W Steffes
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

3.  Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives.

Authors:  K Kario; T G Pickering; T Matsuo; S Hoshide; J E Schwartz; K Shimada
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

4.  Subcortical silent brain infarction as a risk factor for clinical stroke.

Authors:  S Kobayashi; K Okada; H Koide; H Bokura; S Yamaguchi
Journal:  Stroke       Date:  1997-10       Impact factor: 7.914

5.  Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects?

Authors:  S M Haffner; M P Stern; M K Gruber; H P Hazuda; B D Mitchell; J K Patterson
Journal:  Arteriosclerosis       Date:  1990 Sep-Oct

Review 6.  Diabetes, hypertension, and cardiovascular disease: an update.

Authors:  J R Sowers; M Epstein; E D Frohlich
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

7.  Microalbuminuria predicts mortality in non-insulin-dependent diabetics.

Authors:  R J Jarrett; G C Viberti; A Argyropoulos; R D Hill; U Mahmud; T J Murrells
Journal:  Diabet Med       Date:  1984-05       Impact factor: 4.359

8.  Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients.

Authors:  L Niskanen; M Uusitupa; H Sarlund; O Siitonen; E Voutilainen; I Penttilä; K Pyörälä
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

9.  Greater impact of coexistence of hypertension and diabetes on silent cerebral infarcts.

Authors:  Kazuo Eguchi; Kazuomi Kario; Kazuyuki Shimada
Journal:  Stroke       Date:  2003-09-18       Impact factor: 7.914

10.  Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

Authors:  J Stamler; O Vaccaro; J D Neaton; D Wentworth
Journal:  Diabetes Care       Date:  1993-02       Impact factor: 19.112

View more
  3 in total

1.  Masked hypertension in diabetes mellitus: a potential risk.

Authors:  Kazuo Eguchi; Joji Ishikawa; Satoshi Hoshide; Thomas G Pickering; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-08       Impact factor: 3.738

2.  Ambulatory blood pressure monitoring in diabetes and obesity-a review.

Authors:  Kazuo Eguchi
Journal:  Int J Hypertens       Date:  2011-03-28       Impact factor: 2.420

3.  Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients.

Authors:  Alessandra Di Flaviani; Fabiana Picconi; Paola Di Stefano; Ilaria Giordani; Ilaria Malandrucco; Paola Maggio; Paola Palazzo; Fabrizio Sgreccia; Carlo Peraldo; Fabrizio Farina; Gaetano Frajese; Simona Frontoni
Journal:  Diabetes Care       Date:  2011-05-24       Impact factor: 19.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.